Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is high-dose ursodeoxycholic acid effective for the treatment of patients with primary sclerosing cholangitis?

Nature Clinical Practice Gastroenterology & Hepatology volume 3, pages 248–249 (2006)Cite this article

boxed-textOlsson R et al. (2005) High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 129: 1464–1472

The efficacy of high-dose ursodeoxycholic acid in primary sclerosing cholangitis remains an open question

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Pardi DS et al. (2003) Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 124: 889–893

    Article  CAS  Google Scholar 

  2. Harnois DM et al. (2001) High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. Am J Gastroenterol 96: 1558–1562

    Article  CAS  Google Scholar 

  3. Mitchell SA et al. (2001) A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 121: 900–907

    Article  CAS  Google Scholar 

  4. Rost D et al. (2004) Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. Hepatology 40: 693–698

    Article  CAS  Google Scholar 

  5. Stiehl A (2002) Primary sclerosing cholangitis: neoplastic potential in bile ducts, colon and the pancreas? J Hepatol 36: 433–434

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Associate Professor of Hepatology the Service d'Hépatologie et Centre de Référence des Maladies Inflammatoires du Foie et des Voies Biliaires, Hôpital Saint-Antoine, Université Pierre et Marie Curie, Paris, France

    Olivier Chazouillères

  2. Assistant Professor of Hepatology at the Service d'Hépatologie et Centre de Référence des Maladies Inflammatoires du Foie et des Voies Biliaires, Hôpital Saint-Antoine, Université Pierre et Marie Curie, Paris, France

    Christophe Corpechot

Authors
  1. Olivier Chazouillères
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christophe Corpechot
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Olivier Chazouillères.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chazouillères, O., Corpechot, C. Is high-dose ursodeoxycholic acid effective for the treatment of patients with primary sclerosing cholangitis?. Nat Rev Gastroenterol Hepatol 3, 248–249 (2006). https://doi.org/10.1038/ncpgasthep0493

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0493

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing